Axon Enterprise — Feb 25, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001069183-25-000015
Showing in the filing
Moonshot goal to cut gun-related deaths between police and the public
“50%”
Period
FY2033
Measure
Company-defined measure
Source
Prose
All guidance in this release · 11
Adjusted EBITDA for FY2025
“$640 million to $670 million”
Adjusted EBITDA dollars for FY2025
“$640 million to $670 million”
Software-only gross margin target for the long term
“80%”
Remainder of future contracted bookings expe… for the long term
“over the following ten years”
Revenue for FY2025
“$2.55 billion to $2.65 billion”
Adjusted EBITDA margin for FY2025
“approximately 25%”
Stock-based compensation expenses for FY2025
“approximately $580 million to $630 million”
Stock-based compensation expense related to … for FY2025
“approximately $325 million”
CapEx for FY2025
“$140 million to $180 million”
Portion of future contracted bookings expect…
“between 20% to 25%”
Moonshot goal to cut gun-related deaths betw… for FY2033
“50%”
Exhibit 99.1 · the passage around this item
… earlier in the release
As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies. About Axon Axon is a technology leader in global public safety. Our moonshot goal is to cut gun-related deaths between police and the public by 50% before 2033. Axon is building the public safety operating system of the future by integrating a suite of hardware devices and cloud software solutions that lead modern policing. Axon’s suite includes TASER energy devices, body cameras, in-car cameras, robotic security and training, cloud-hosted digital evidence management solutions, productivity software and real-time operations capabilities. Axon’s growing global customer base includes first responders across international, federal, state and local law enforcement, fire, corrections and emergency medical services, as well as the justice sector, enterprises and consumers. Non-Axon trademarks are property of their respective owners. Axon, Axon Air, Axon Body, Axon Body Workforce, Axon Evidence, Axon Fleet, Axon Fusus, Dedrone, Draft One, TASER, TASER 10, the Filled Bolt within Circle Logo and the Delta Logo are trademarks of Axon Enterprise, Inc., some of which are registered in the United States and other countries. For more information, visit www.axon.com/legal. All rights reserved. Forward-looking Statements Forward-looking statements in this letter include, without limitation, statements regarding: proposed products and service
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.